መነሻ › የዩዊንግ ሳርኮማ › ዲስትሪክት ኦፍ ኮሎምቢያ
በዲስትሪክት ኦፍ ኮሎምቢያ ለየዩዊንግ ሳርኮማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለየዩዊንግ ሳርኮማ የሚደረጉ 6 ጥናቶች በዲስትሪክት ኦፍ ኮሎምቢያ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በዲስትሪክት ኦፍ ኮሎምቢያ ውስጥ ያሉ ከተሞች
Official study text (English)
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
- Children's National Hospital, Washington D.C.
- Childrens National Hospital, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 23 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT07172958Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Sibley Memorial Hospital, Washington D.C.
ተሳታዮችን በመፈለግ ላይ
እስከ እድሜ 39 · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT06796543Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ19 ሜይ 2026 · NCT04901702Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's National Hospital, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ2 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ3 ፌብሩ 2026 · NCT05734066A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 2
18 Months – 40 Years · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2025 · NCT05135975ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።